PACS Group and Nutex Health Lead Earnings Momentum After Hours, Zynex and Genenta Advance

PACS Group surged 45.48% after hours to $24.48, while Nutex Health advanced 9.64% to $123.00. Zynex and Genenta Science also posted notable gains after hours. Earnings announcements and recent financing updates drove activity across healthcare, biotech, and technology names. PACS Group reported Q3 net income of $52.4 million, with revenue rising to $1.345 billion. Nutex Health reported Q3 net income of $55.4 million, with revenue climbing to $267.8 million.